Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 15,000 shares at $65.31 ($981K) on 2018-08-15, disclosed to the SEC on 2018-08-17.
Open-market sale of $981k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.31 | 6,199 | $405K | 41.3% |
| 2 | $65.31 | 6,199 | $405K | 41.3% |
| 3 | $65.99 | 1,301 | $86K | 8.7% |
| 4 | $65.99 | 1,301 | $86K | 8.7% |
| Total | $65.43 avg | 15,000 | $981K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |